Pathogenesis of rheumatoid arthritis: basis for future therapies.
Despite an increase in the number of rheumatologists in clinical practice over the past 15 years, the outcome for patients with rheumatoid arthritis (RA) remains relatively poor. The poor prognosis for patients with this disease is due to a lack of effective therapies. Better therapies will be developed only after the cause and pathogenesis of RA are better understood. Although the precise cause is unknown, a variety of evidence indicates that RA results from the presentation of a relevant antigen to an immunogenetically susceptible host. This report reviews recognized potential antigens and known genetic variables affecting the immune response, as well as the various cellular and humoral immune responses that result from the antigen-host interaction. More successful therapy for RA will most certainly result from a better understanding of the pathobiology of the disease.
Wortmann
R L
RL
Medical Service, Clement J. Zablocki Veterans Administration Medical Center, Milwaukee, WI.
D000917:Antibody Formation; D001172:Arthritis, Rheumatoid / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D016207:Cytokines / Q000502:physiology; D004198:Disease Susceptibility; D005544:Forecasting; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D007125:Immunogenetics; D008214:Lymphocytes / Q000502:physiology
D016207:Cytokines; D006680:HLA Antigens